Brendon Boot, MBBS, is a neurologist at Brigham and Women’s Hospital, an instructor in neurology at Harvard Medical School, fellow of the Royal Australasian College of Physicians,  member of the American Academy of Neurology and the Australia and New Zealand Association of Neurologists, and alumnus of Mayo Clinic School of Medicine.

His research is focused upon Parkinson’s disease and dementia with Lewy bodies. He publishes on the clinical and genetic risk factors, biomarkers, progression and treatment of these diseases. He also publishes on genetic, biomarker, imaging and pathological findings in other neurodegenerative diseases such Alzheimer’s disease and frontotemporal dementia.

Dr. Boot collaborates with Dr. Clemens Scherzer to develop genetic markers of diagnosis and disease progression of Parkinson’s disease at The Neurogenomics Laboratory at Harvard Medical School and the Harvard NeuroDiscovery Center Biomarkers Program. He is co-principal investigator for MRI and PET imaging studies at Massachusetts General, and Brigham and Women’s and Hospitals, and the Martinos Center for Biomedical Imaging. He also conducts treatment trials at the Center for Alzheimer’s Research and Treatment based at Brigham and Women’s Hospital.